As research on coronavirus vaccines continues to expand around the world, more and more clinical trials are entering Louisiana.
Pfizer is testing the latest products. Ochsner Health System officials announced on Friday that they will conduct clinical trials on the coronavirus vaccine being developed by the pharmaceutical giant at 120 sites around the world. Benchmark Research based on Metairie is also working on this vaccine.
After the coronavirus vaccine showed encouraging results in a 45-person study conducted by the biotechnology company Moderna, the New Orleans study site…
Dr. Julia Garcia-Diaz, director of clinical infectious disease research at Ochsner, said she hopes that this clinical trial can recruit 200 to 300 participants. She said that many patients in Ochsner have expressed interest in participating in coronavirus research, and these patients will be the first target of their help. They are looking for people over 18 and under 85.
Those who participate in the study will be given two shots and will be followed for 24 months. Half of the participants will receive the vaccine, and the other half will receive a placebo. Neither the patients nor the medical staff who conducted the study would know which photo they received. Pfizer hopes to recruit 30,000 participants worldwide.
Garcia-Diaz (Garcia-Diaz) said that Ochsner will pay close attention to patients and record any side effects that may occur, from pain at the injection site to fever. Doctors will also pay close attention to whether the patient has any respiratory infections, which may indicate that they have been infected with the coronavirus and the vaccine (if a placebo is not available) is not effective in preventing respiratory infections.
When Dr. Joshua Denson was treating a coronavirus patient who needed a ventilator in April, he decided to give him steroids,…
Although vaccines usually take several years to develop, as researchers around the world seek answers on how to stop the spread of the coronavirus, pharmaceutical companies have been working hard to test its possibility.
Garcia-Diaz said the public should know that the necessary safeguards are in place.
She said: “Just because we are trying to complete this process quickly does not mean we are skipping any steps.”
The Pfizer clinical trial was the first trial Ochsner participated in, but there are other trials around the state. The Meridian clinical study in Baton Rouge and Benchmark in Jefferson Parish are also working on vaccines from the biotech company Moderna.
Doctors in Louisiana faced a disturbing situation in early March, when coronavirus patients began to appear in the state’s intensive care unit…
The Moderna vaccine is the first vaccine tested on humans in the United States. The company began recruiting personnel to participate in the second round of clinical trials on Monday. After the mRNA vaccine study of 45 people showed encouraging results, Moderna launched a larger study that included 30,000 test participants.
Maybe more clinical trials are about to start. Researchers at the University of Oxford in the United Kingdom are accelerating vaccine development in the final stages of clinical trials, and it is expected that certain studies will eventually enter the United States. Johnson & Johnson researchers announced this week that their experimental coronavirus vaccine will begin human trials after vaccination. The vaccine shows hope in monkeys.
According to data from the World Health Organization, there are currently 26 candidate vaccines in the clinical evaluation of coronavirus.
As of Friday, Louisiana has reported 116,280 coronavirus cases and 3,835 deaths. Garcia-Diaz said that people should not be wary of the imminent vaccine.
The state has not yet reached herd immunity, and the coronavirus is easily spread. She urged people to continue to wash their hands, wear masks and maintain social distancing.
When the first case of coronavirus was diagnosed in Louisiana on March 9, doctors had little information about the disease.